Using a dye to help see cancer during vulvectomy for Paget's disease
Part of Cancer clinical trials.
This trial tests whether a fluorescent dye called fluorescein sodium can help surgeons see the edges of extramammary Paget's disease more clearly during vulvectomy, so they can remove all the cancer while sparing as much healthy tissue as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a type of Paget's disease (EMPD) that has not spread deep into the skin or beyond
- Your EMPD appears as a single, connected spot that the surgeon can see
- Your doctor plans to remove the cancer with surgery that does not require removing the clitoris, urethra, or anus, and expects to close the wound directly or with a simple skin flap
- You have not had an allergic reaction to fluorescein sodium in the past
- You have not had radiation therapy to the vulva or anus area
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for women with a specific rare skin cancer called extramammary Paget’s disease (EMPD) in the vulvar or perianal area. The goal is to better understand the condition and test an approach for people with primary or returning (recurrent) disease in those locations.
This trial tests a dye (CYTALUX) that helps surgeons see endometrial cancer during surgery. You may be eligible if you have endometrial cancer and are scheduled for surgery.
This trial tests a dye that makes lung cancer cells glow during surgery, helping surgeons remove more of the tumor. It's for people who are already scheduled for lung cancer surgery.
This study tests a special light treatment (photodynamic therapy) for non-invasive Paget’s disease on the vulva that has come back after surgery. It may help by treating remaining abnormal skin cells where surgery may not remove everything.
This trial tests whether a fluorescent dye applied to tissue during surgery helps doctors see tumors and check if the tumor removal is complete. If you have a solid tumor and are scheduled for surgery, this study may improve the precision of your operation.
This trial checks whether using a dye (fluorescein) during certain gynecologic surgeries helps doctors get clearer information during the operation. It’s for people who are already planned for laparoscopic surgery for common gynecologic conditions or cancers.
Hear when a new Extramammary Paget's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.